法国慢性肺曲霉病的患病率、易感肺部疾病与预后
首次住院、1年及5年死亡率分别为17%、32%和45%。
要点
- CPA住院患者中慢阻肺和肺气肿常见,结核及非结核分枝杆菌感染比例低。
- 住院CPA患者1年死亡率32%,5年死亡率45%。
- 年龄>65岁、男性、营养不良、糖尿病及肺癌史与死亡率升高相关。
核心结论
- 在法国,CPA是与非分枝杆菌性慢性肺部疾病常见相关的新发感染,基础疾病分布变化可能加重CPA死亡率。
研究设计与样本
- 研究利用法国全国行政住院数据库,估计2009至2018年住院CPA患者的患病率和死亡率,并评估与慢性肺部疾病、胸部干预及营养不良的关联。
主要发现
- 患者多为男性(63.5%),诊断时中位年龄65岁,多居住在农业地区和大城市。
- 既往5年内慢阻肺和肺气肿比例分别为44%和22%,而结核和非结核分枝杆菌感染比例均仅3%。
- 首次住院、1年和5年死亡率分别为17%、32%和45%。
- 多因素分析显示,年龄>65岁、男性、营养不良、糖尿病或肺癌史患者死亡率增加;慢阻肺或肺气肿患者死亡风险高于既往分枝杆菌肺部感染患者。
临床怎么用
- 在低结核发病率国家,对慢阻肺、肺气肿等慢性肺部疾病患者应警惕CPA可能。
- 住院CPA患者预后较差,需关注高龄、男性、营养不良、糖尿病及肺癌史等高死亡风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic pulmonary aspergillosis (CPA) is an emerging disease in patients with common chronic pulmonary diseases (CPDs). While its prevalence is linked to tuberculosis (TB) in endemic countries, epidemiological and prognostic data are lacking in low TB incidence countries. The aim of this study was to describe these features in CPA patients hospitalised in France between 2009 and 2018.We estimated the prevalence and mortality of hospitalised CPA patients using the French nationwide administrative hospital database. We also assessed the association with CPD, thoracic interventions and malnutrition.From 2009 to 2018, 17 290 patients were hospitalised in France for CPA, with an increasing prevalence during this period. Most patients were male (63.5%) with a median age of 65 years at CPA diagnosis, living in farming regions and large cities. The proportion of underlying chronic obstructive pulmonary disease (COPD) and emphysema during the previous 5 years was 44% and 22%, respectively, whereas it was only 3% for both TB and non-TB mycobacterial (NTM) infections. The mortality rates during the first hospitalisation, at 1 year and at 5 years were 17%, 32% and 45%, respectively. In multivariate analysis, mortality rates were increased in patients aged >65 years, male patients and patients with malnutrition, diabetes or lung cancer history. The risk of mortality in patients with COPD or emphysema was higher than in those with previous mycobacterial lung infection.In France, CPA is an emerging infection commonly associated with non-mycobacterial CPD. This shift in the distribution profile of underlying CPD will likely worsen CPA mortality.
引用
- Maitre T, Cottenet J, Godet C, et al. Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis. Eur Respir J. 2021. PMID: 33479108. doi:10.1183/13993003.03345-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。